Purpose: To determine the prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) among patients with age-related macular degeneration (AMD).
Design: A prospective study with a nested case-control study of consecutive patients with AMD seen in a referral retinal practice.
Participants: There were 153 patients with AMD, 131 of whom had > or =1 eye with late AMD, which was defined as either central geographic atrophy or choroidal neovascularization. The control group consisted of 101 patients who did not have AMD as their primary diagnosis, central serous chorioretinopathy, high myopia, retinal detachment, or laser treatment in the macular area.
Methods: The presence of subretinal drusenoid deposits was determined by 2 methods, using the blue channel of color fundus photograph and the spectral domain optical coherence tomography (SD-OCT) sections. Soft drusen were determined from color fundus photographs and confirmed by SD-OCT.
Main Outcome Measures: Prevalence of ocular risk factors and subretinal drusenoid deposits in eyes with AMD and their association with late AMD.
Results: There were 153 patients who had any form of AMD, with a mean age of 80.3 years. Subretinal drusenoid deposits were diagnosed in the case group in 13 (8.7%) of right and 18 (12.0%) of left eyes using the blue channel of the color photograph and in 58 (38.4%) of right and 54 (35.8%) of left eyes using SD-OCT. Soft drusen and subretinal drusenoid deposits detected by SD-OCT were found to be independently correlated with late AMD (soft drusen odds ratio = 16.66 [P<0.001]; subretinal drusenoid deposits as detected by OCT odds ratio = 2.64 [P = 0.034]). In the control group, subretinal drusenoid deposits were diagnosed in 6 (6.5%) of right and 6 (6.3%) of left eyes using SD-OCT.
Conclusions: Both soft drusen and subretinal drusenoid deposits occur in patients with AMD and both are significantly associated with late AMD. These findings suggest that detection and classification of drusen and consequently assignment of risk should be based on a methodology that includes SD-OCT.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ophtha.2010.01.027 | DOI Listing |
Am J Ophthalmol
November 2024
From the Harvard Retinal Imaging Lab (C.B., F.R., F.V., M.G., X.D., A.B., I.P., I.S., K.O., G.B., I.G., J.R., I.L., L.A. K., and J.B.M.), Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA; Department of Ophthalmology (F.R., X.D., D.N., G.B., R.B., I.L., L.A. K., D.V., D.H., J.W.M., and J.B. M.), Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, USA. Electronic address:
Purpose: Establishing associations between structure, function, and clinical outcomes in intermediate age-related macular degeneration (iAMD) remains an unmet need. This study aims to (1) cross-sectionally investigate the relationships between optical coherence tomography (OCT) biomarkers and quantitative contrast sensitivity function (qCSF)-measured contrast sensitivity (CS), and (2) longitudinally assess their relationship with progression from iAMD to late stages of the disease.
Design: Cross-sectional and cohort study.
Sci Rep
November 2024
Laboratory for Ophthalmic Image Analysis (OPTIMA), Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
To examine the morphological impact of deep learning (DL)-quantified biomarkers on point-wise sensitivity (PWS) using microperimetry (MP) and optical coherence tomography (OCT) in intermediate AMD (iAMD). Patients with iAMD were examined by OCT (Spectralis). DL-based algorithms quantified ellipsoid zone (EZ)-thickness, hyperreflective foci (HRF) and drusen volume.
View Article and Find Full Text PDFSci Rep
October 2024
Ophthalmology Department, Hadassah Medical Center, Jerusalem, Israel.
Int J Retina Vitreous
October 2024
Hospital De Olhos Do Paraná, 483, Presidente Taunay St. Alameda Presidente Taunay, 483 Batel, Curitiba, CEP 80420-180, PR, Brazil.
Ophthalmic Genet
December 2024
Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!